

IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel
Dec 18, 2023
Dr. Neela Patel and Dr. John Mulligan discuss Bonum Therapeutics' transition from Good Therapeutics, the Roche acquisition, challenges faced by early-stage biotech companies, and creating a better path for women in biotech.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Transitioning into the Biotech Industry
01:36 • 23min
Roche Acquisition and Deal Structure
24:07 • 13min
Challenges Faced by Early-Stage Biotech Companies and Collaboration with Cytiva
37:00 • 2min
Excitement and Celebration for Program Continuation
39:27 • 20min
Creating a Better Path for Women in Biotech
59:20 • 8min
Dr. Mulligan's Work Setup and Appreciation for the Conversation
01:06:54 • 2min